Product Information
RUFINAMIDE 40 MG/ML SUSPENSION is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2036 per ML under NDC 59651056360. Its NADAC has been published 172 times since May 10, 2023.
FDA first approved this application on Oct 26, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/mL
Manufacturer
Aurobindo Pharma LimitedNDC
59651056360
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RUFINAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216549FDA Approved
10/26/2022
TE Code
AB
On Market Since
10/26/2022
Price Statistics
The NADAC for RUFINAMIDE 40 MG/ML SUSPENSION has been published 172 times since May 10, 2023, and over the history we have for it it has declined 79.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2036 per ML |
|---|---|
| All-time high | $1.4122 (Aug 16, 2023) |
| All-time low | $0.2021 (Jul 22, 2026) |
| 52-week high | $0.3887 |
| 52-week low | $0.2021 |
| Median price | $0.3794 |
| Average price | $0.4889 |
| Largest weekly change | -53.3% (Sep 20, 2023) |
| Weeks tracked | 172 |
| Tracking since | May 10, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the RUFINAMIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RUFINAMIDE 40 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for RUFINAMIDE 40 MG/ML SUSPENSION, manufactured by Aurobindo Pharma Limited, is $0.2036 per ML (NDC 59651056360), effective Aug 19, 2026.
How has the price of RUFINAMIDE 40 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for RUFINAMIDE 40 MG/ML SUSPENSION has declined 79.6%. It has been tracked across 172 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for RUFINAMIDE 40 MG/ML SUSPENSION?
Since May 10, 2023, the NADAC for RUFINAMIDE 40 MG/ML SUSPENSION has ranged from a low of $0.2021 (Jul 22, 2026) to a high of $1.4122 (Aug 16, 2023), with a median of $0.3794 per ML.
Are there cheaper alternatives to RUFINAMIDE 40 MG/ML SUSPENSION?
No other NADAC-published product currently shares the active ingredient and strength of RUFINAMIDE 40 MG/ML SUSPENSION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RUFINAMIDE 40 MG/ML SUSPENSION?
RUFINAMIDE 40 MG/ML SUSPENSION (NDC 59651056360) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.